Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 3/2018

01-08-2018 | Review Article

Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis

Authors: Tian-Tian Lv, Peng Wang, Shi-Yang Guan, Hong-Miao Li, Xiao-Mei Li, Bin Wang, Hai-Feng Pan

Published in: Irish Journal of Medical Science (1971 -) | Issue 3/2018

Login to get access

Abstract

Background and aims

Pulmonary hypertension (PH) has been suggested to be associated with systemic lupus erythematosus (SLE). However, the results of prevalence studies on PH in SLE vary substantially. To derive a more precise estimation on the prevalence of PH in SLE, a meta-analysis was performed.

Methods

Relevant literatures were searched in PubMed and EMBASE until November 2017. A total of 1366 articles were obtained after searching databases, and 23 studies were finally included in the meta-analysis. Heterogeneity test was performed, and publication bias was evaluated.

Results

The result of analysis in random effect model showed that the pooled prevalence was 8% (95%CI 5–12%). There was no evidence of publication bias (p = 0.51). To evaluate the stability of our results, sensitivity analyses were performed, and the results showed no significant change when any one study was excluded. Subgroup analyses demonstrated that there were significant differences in PH prevalence in SLE patients of different gender, age, regions, year of publication, and diagnostic methods.

Conclusions

PH is prevalent in SLE patients, but it was significantly different between different gender, age, regions, year of publication, and diagnostic methods.
Literature
9.
go back to reference Charoenpan P, Sukumalchantra Y, Ayuthya WI (1977) Pulmonary hypertension in systemic lupus erythematosus: a case report. J Med Assoc Thail 60:670–675 Charoenpan P, Sukumalchantra Y, Ayuthya WI (1977) Pulmonary hypertension in systemic lupus erythematosus: a case report. J Med Assoc Thail 60:670–675
12.
go back to reference Ling-Te Pan T, Thumhoo J, Boey M-L (2000) Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 9:338–342CrossRef Ling-Te Pan T, Thumhoo J, Boey M-L (2000) Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 9:338–342CrossRef
16.
go back to reference Charles H (2004) Pulmonary hypertension associated with systemic lupus erythematosus. Bulletin De Lacadémie Nationale De Médecine 188:985–997 discussion 997 Charles H (2004) Pulmonary hypertension associated with systemic lupus erythematosus. Bulletin De Lacadémie Nationale De Médecine 188:985–997 discussion 997
18.
go back to reference Winslow TM, Ossipov MA, Fazio GP, Simonson JS et al (1995) Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 129:510–515CrossRefPubMed Winslow TM, Ossipov MA, Fazio GP, Simonson JS et al (1995) Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 129:510–515CrossRefPubMed
20.
go back to reference Luo ML, Tan HZ, Zhou Q et al (2013) Realizing the meta-analysis of single rate in R software. The. J Evid -Based Med 13(3):181–184 Luo ML, Tan HZ, Zhou Q et al (2013) Realizing the meta-analysis of single rate in R software. The. J Evid -Based Med 13(3):181–184
23.
go back to reference Elias Badui, David Garcia-Rubi, Elsa Robles, Javier Jimenez, Lourdes Juan, Margarita Deleze, et al. (1985) Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology-Journal of Vascular Diseases 431–442 Elias Badui, David Garcia-Rubi, Elsa Robles, Javier Jimenez, Lourdes Juan, Margarita Deleze, et al. (1985) Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology-Journal of Vascular Diseases 431–442
24.
go back to reference Tanaka E, Harigai M, Tanaka M, Kawaguchi Y, Hara M, Kamatani N (2002) Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. J Rheumatol 29(2):282–287PubMed Tanaka E, Harigai M, Tanaka M, Kawaguchi Y, Hara M, Kamatani N (2002) Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. J Rheumatol 29(2):282–287PubMed
28.
go back to reference Foïs E, Le Guern V, Dupuy A, Humbert M, Mouthon L, Guillevin L (2010) Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. Clin Exp Rheumatol 28:836–841PubMed Foïs E, Le Guern V, Dupuy A, Humbert M, Mouthon L, Guillevin L (2010) Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. Clin Exp Rheumatol 28:836–841PubMed
29.
go back to reference Bourré-Tessier J, Huynh T, Clarke AE, Bernatsky S, Joseph L, Belisle P et al (2011) Features associated with cardiac abnormalities in systemic lupus erythematosus. Lupus 20:1518–1525CrossRefPubMed Bourré-Tessier J, Huynh T, Clarke AE, Bernatsky S, Joseph L, Belisle P et al (2011) Features associated with cardiac abnormalities in systemic lupus erythematosus. Lupus 20:1518–1525CrossRefPubMed
33.
go back to reference Ruiz-Irastorza G, Garmendia M, Villar I, Egurbide MV, Aguirre C (2013) Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy. Autoimmun Rev 12:410–415CrossRefPubMed Ruiz-Irastorza G, Garmendia M, Villar I, Egurbide MV, Aguirre C (2013) Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy. Autoimmun Rev 12:410–415CrossRefPubMed
34.
go back to reference Li M, Wang Q, Zhao J, Li Z, Ye Z, Li C, Li X, Zhu P, Wang Z, Zheng Y, Li X, Zhang M, Tian Z, Liu Y, He J, Zhang F, Zhao Y, Zeng X, CSTAR co-authors (2014) Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus. Lupus 23(10):1085–1091. https://doi.org/10.1177/0961203314527366 CrossRefPubMed Li M, Wang Q, Zhao J, Li Z, Ye Z, Li C, Li X, Zhu P, Wang Z, Zheng Y, Li X, Zhang M, Tian Z, Liu Y, He J, Zhang F, Zhao Y, Zeng X, CSTAR co-authors (2014) Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus. Lupus 23(10):1085–1091. https://​doi.​org/​10.​1177/​0961203314527366​ CrossRefPubMed
36.
go back to reference Ki-Jo KIM, In-Woon BAEK, Yune-Jung PARK, Chong-Hyeon YOON, Wan-Uk KIM, CHO C-S (2015) High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension. International Journal of Rheumatic Diseases 524–532 Ki-Jo KIM, In-Woon BAEK, Yune-Jung PARK, Chong-Hyeon YOON, Wan-Uk KIM, CHO C-S (2015) High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension. International Journal of Rheumatic Diseases 524–532
37.
go back to reference Ware D, Sharma V, Kalekar L, Kamble A, Mahajan A, Gokhale Y (2015) Higher incidence of pulmonary hypertension in antiphospholipid antibody positive lupus. J Assoc Physicians India 63(4):17–20PubMed Ware D, Sharma V, Kalekar L, Kamble A, Mahajan A, Gokhale Y (2015) Higher incidence of pulmonary hypertension in antiphospholipid antibody positive lupus. J Assoc Physicians India 63(4):17–20PubMed
39.
go back to reference Hachulla E, Jais X, Cinquetti G, Clerson P, Rottat L, Launay D, et al. (2017) Pulmonary arterial hypertension associated with systemic lupus erythematosus: results from the French Pulmonary Hypertension Registry. Chest Hachulla E, Jais X, Cinquetti G, Clerson P, Rottat L, Launay D, et al. (2017) Pulmonary arterial hypertension associated with systemic lupus erythematosus: results from the French Pulmonary Hypertension Registry. Chest
40.
go back to reference Ghofraniha L, Mirfeizi Z, Khabbaz FS, Vakilian F, Eslami S (2017) Correlation of echocardiographic findings of pulmonary hypertension with six-minute walk test and plasma pro b-type natriuretic peptide level in systemic lupus erythematous. Electron Physician 9(8):5122–5128CrossRefPubMedPubMedCentral Ghofraniha L, Mirfeizi Z, Khabbaz FS, Vakilian F, Eslami S (2017) Correlation of echocardiographic findings of pulmonary hypertension with six-minute walk test and plasma pro b-type natriuretic peptide level in systemic lupus erythematous. Electron Physician 9(8):5122–5128CrossRefPubMedPubMedCentral
41.
go back to reference Luo RQ, Lei YX, Zhang X, Fei L (2008) Clinical analysis of patients with systemic lupus erythematosus and concomitant pulmonary hypertension. J South Med Univ 28:1860–1863 Luo RQ, Lei YX, Zhang X, Fei L (2008) Clinical analysis of patients with systemic lupus erythematosus and concomitant pulmonary hypertension. J South Med Univ 28:1860–1863
42.
go back to reference Xing Y, Song HM, Wu XY, He YY, Min W (2008) Clinical analysis and pulmonary arterial hypertension secondary to connective tissue disease in children. CLIN J Pedistr 46:822–826 Xing Y, Song HM, Wu XY, He YY, Min W (2008) Clinical analysis and pulmonary arterial hypertension secondary to connective tissue disease in children. CLIN J Pedistr 46:822–826
44.
go back to reference Li-Ju Chen, Hung-Chou Chang, Ling-Ying Lu, Jui-Cheng Tseng, Jui-Chieh Hu, Chien-Kai Kau, et al(2004) Prolonged survival after single lung transplantation for pulmonary hypertension secondary to systemic lupus erythematosus. J Chin Med Assoc 248-251 Li-Ju Chen, Hung-Chou Chang, Ling-Ying Lu, Jui-Cheng Tseng, Jui-Chieh Hu, Chien-Kai Kau, et al(2004) Prolonged survival after single lung transplantation for pulmonary hypertension secondary to systemic lupus erythematosus. J Chin Med Assoc 248-251
45.
go back to reference Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G (2006) Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173(9):1023–1030. https://doi.org/10.1164/rccm.200510-1668OC CrossRefPubMed Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G (2006) Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173(9):1023–1030. https://​doi.​org/​10.​1164/​rccm.​200510-1668OC CrossRefPubMed
46.
go back to reference Hsu VM, Moreyra AE, Wilson AC et al (2008) Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 35(3):458–465PubMed Hsu VM, Moreyra AE, Wilson AC et al (2008) Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 35(3):458–465PubMed
48.
go back to reference Asherson RA, Higenbottam TW, Dinh Xuan AT et al (1990) Pulmonary hypertension in a lupus clinic. Experience with twenty-four patients. J Rheumatol 17(10):1292–1298PubMed Asherson RA, Higenbottam TW, Dinh Xuan AT et al (1990) Pulmonary hypertension in a lupus clinic. Experience with twenty-four patients. J Rheumatol 17(10):1292–1298PubMed
Metadata
Title
Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis
Authors
Tian-Tian Lv
Peng Wang
Shi-Yang Guan
Hong-Miao Li
Xiao-Mei Li
Bin Wang
Hai-Feng Pan
Publication date
01-08-2018
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 3/2018
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-017-1727-4

Other articles of this Issue 3/2018

Irish Journal of Medical Science (1971 -) 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.